FDA Drug Safety Podcasts

The FDA Drug Safety Podcasts are produced by FDA's Center for Drug Evaluation and Research (CDER). They provide emerging safety information about drugs in conjunction with the release of Public Health Advisories and other drug safety issues.   

 

Latest Drug Safety Podcasts

Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)	May 14, 2012	Run Time: 00:03:47		Transcript
Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies	May 7, 2012	Run Time: 00:03:02		Transcript
Updated information on drug interactions between Victrelis (boceprevir) and certain boosted HIV protease inhibitor drugs	April 26, 2012	Run Time: 00:03:55		Transcript
New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna)	April 20, 2012	Run Time: 00:03:45		Transcript
Updated information about the risk of blood clots in women taking birth control pills containing drospirenone	April 11, 2012	Run Time: 00:03:04		Transcript
Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses	March 30, 2012	Run Time: 00:05:29		Transcript
Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury	March 2, 2012	Run Time: 00:02:22		Transcript
Important safety label changes to cholesterol-lowering statin drugs	March 2, 2012	Run Time: 00:03:37		Transcript
Important drug interactions between Victrelis (boceprevir) and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitor drugs	February 10, 2012			Transcript
Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)	February 8, 2012			Transcript
New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)	January 20, 2012	Run Time: 00:04:54		Transcript
New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin)	January 13, 2012	Run Time: 00:04:21		Transcript
Update - Preliminary findings from ongoing investigations of CardioGen-82	January 13, 2012	Run Time: 00:04:38		Transcript

View All Past Podcasts